Tag: $CVS

CVS Health on Thursday reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook, as it sees strength in its retail pharmacy business and some improvement in its insurance unit.

CVS Health on Thursday reported first-quarter earnings and revenue that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period.

The pharmacy chain is opening around a dozen stores this year that are about the half the size of its traditional layout and have only a pharmacy — ditching the front-end of the store that traditionally has sold snack, greeting cards and other consumer staples.

CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as its pace of medical cost increases slowed and revenue at its pharmacy business jumped, sending its shares up more than 12% in premarket trading.

CVS Health on Wednesday reported mixed third-quarter results as higher medical costs squeezed its bottom line. The earnings report is CEO David Joyner’s first at the helm of the troubled retail drugstore chain.

CVS Health Corp.’s stock tumbled 10.5% early Friday, after the healthcare company announced leadership changes and lowered guidance for the fourth time this year, weighed down by challenges in its health-benefits business.

CVS Health’s board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter, as the company contends with potential activist pressure and a severely depressed stock price.

Glenview Capital, a major CVS Health shareholder, is expected to meet with company leadership on Monday to lay out proposed fixes for the struggling business, according to people familiar with the matter, a potential precursor to an activist push.

CVS Health on Wednesday reported second-quarter earnings that topped expectations, but slashed its full-year profit outlook, citing higher medical costs that have been squeezing the U.S. insurance industry

CVS Health stock tumbled Wednesday after pharmacy chain missed Wall Street’s expectations for quarterly earnings and dramatically slashed its full-year financial guidance. To blame was soaring Medicare Advantage costs that have similarly slammed its peers.

Shares of CVS Health Corp. gained ground Wednesday, after the healthcare-services and drugstore chain beat fourth-quarter profit expectations by a wide margin, but lowered its full-year outlook because of “elevated medical cost trends.”

Investors didn’t seem pleased with a solid earnings and revenue beat from CVS Health with shares in the healthcare company heading lower on Wednesday after the company slashed its full-year guidance for the third consecutive quarter.

CVS Health  stock fell Thursday on a report that a major health insurer will drop its pharmacy-benefit management service in favor of a system partially operated by Amazon.com.  

CVS Health CVS –0.99% on Wednesday reported second-quarter earnings that beat analysts’ expectations.

CVS Health Corp. will slash about 5,000 jobs in a cost-cutting move, the Wall Street Journal reported Monday night. According to the report, the layoffs are primarily in corporate positions, and the company doesn’t expect customer-facing positions in its stores, clinics and pharmacies to be affected.